No featured image available
Rep. Tom Price, President-elect Donald Trump’s choice to be his secretary of Health and Human Services may have encountered a little “fake news” by CNN reporters who questioned the ethics of a stock trade he made in the health care field.
CNN charged its “First on CNN” page Monday, “Rep. Tom Price last year purchased shares in a medical device manufacturer days before introducing legislation that would have directly benefited the company.”
CNN also reported, “Less than a week after the transaction, the Georgia Republican congressman introduced the HIP Act, legislation that would have delayed until 2018 a Centers for Medicare and Medicaid Services (CMS) regulation that industry analysts warned would significantly hurt Zimmer Biomet financially once fully implemented.”
CNN’s article was repeated by such news organizations as Reuters, CBS News, New York Magazine, and Forbes.
However, CNN decided to leave out key facts:
How big was the stock transaction that would have allowed Price to clean up? It was 26 shares, amounting to a little less than $2,700.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].